Nadim Ahmed's Net Worth
$8.46 Million
Who is Nadim Ahmed?
Nadim Ahmed has an estimated net worth of $8.46 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, Cullinan Oncology, Inc., and CELGENE CORP /DE/.
SEC CIK
Nadim Ahmed's CIK is 0001731193
Past Insider Trading and Trends
2019 was Nadim Ahmed's most active year for acquiring shares with 46 total transactions. Nadim Ahmed's most active month to acquire stocks was the month of October. 2019 was Nadim Ahmed's most active year for disposing of shares, totalling 39 transactions. Nadim Ahmed's most active month to dispose stocks was the month of October. 2022 saw Nadim Ahmed paying a total of $117,974.00 for 224,710 shares, this is the most they've acquired in one year. In 2020 Nadim Ahmed cashed out on 50,498 shares for a total of $1,474,849.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6
EVP and President, Hematology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.05% | 7.29K |
$62.03 | -$475,149.80 | 38.89K |
Dec 31
| |||
Form 4
| +11.32% | 3.21K |
$62.18 | -$210,168.40 | 31.6K |
Dec 2
| |||
Form 4
| +9.06% | 2.36K |
$58.45 | -$133,908.95 | 28.39K |
Oct 30
| |||
Form 4
| +6.01% | 1.48K |
$60.26 | -$86,352.58 | 26.03K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +55.18% | 8.73K |
$59.06 | -$500,415.38 | 24.55K |
Mar 1
| |||
Form 4
| +6.78% | 1K |
$64.29 | -$68,854.59 | 15.82K |
Feb 4
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
|
∞
| 16.79K |
—
|
—
| 16.79K |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cullinan Oncology, Inc. (CGEM) Snapshot price: $17.98
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +143.43% | 160K |
—
|
—
| 271.55K |
Feb 22
| |||
Form 4
| -3.69% | -4.27K |
$9.24 | -$39,473.28 | 111.55K |
Dec 26
| |||
Form 4
| -0.65% | -759.00 |
$11.40 | -$8,652.60 | 115.82K |
Jun 28
| |||
Form 4
| -0.60% | -707.00 |
$9.15 | -$6,469.05 | 116.58K |
May 23
| |||
Form 4
| -0.61% | -716.00 |
$10.59 | -$7,582.44 | 117.29K |
Apr 25
| |||
Form 4
| -0.59% | -706.00 |
$10.51 | -$7,420.06 | 118K |
Mar 23
| |||
Form 4
| +1,122.55% | 109K |
—
|
—
| 118.71K |
Feb 22
| |||
Form 4
| +20.02% | 1.62K |
$10.90 | $17,658.00 | 9.71K |
Jun 30
| |||
Form 4
|
∞
| 8.09K |
$12.40 | $100,316.00 | 8.09K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CELGENE CORP /DE/ No price found
PRES., GLOBAL HEM. AND ONC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
| -100.00% | -16.79K |
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +17.29% | 2.19K |
$108.03 | -$118,400.88 | 14.82K |
Oct 31
| |||
Form 4
| +9.28% | 1.07K |
$95.21 | -$46,652.90 | 12.63K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +15.17% | 1.52K |
$68.20 | -$100,731.40 | 11.56K |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||